{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:37:33Z","timestamp":1760852253860,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jsbmb.2007.03.033","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T07:17:49Z","timestamp":1174979869000},"page":"180-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Incidences of breast cancer throughout long-term hormone replacement therapy"],"prefix":"10.1016","volume":"104","author":[{"given":"J.","family":"Cort\u00e9s-Prieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Juez-Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2007.03.033_bib1","series-title":"Breast Cancer","first-page":"373","article-title":"Hormone Replacement Therapy, the Menopause, and Breast Cancer","author":"Marsden","year":"2000"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00006250-197907000-00017","article-title":"Estrogen Replacement Therapy II: A prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems","volume":"54","author":"Nachtigall","year":"1979","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib3","first-page":"435","article-title":"Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users","volume":"62","author":"Gambrell","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib4","series-title":"A Clinical Guide for the Care of Older Women","first-page":"133","article-title":"The breast","author":"Byyny","year":"1990"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib5","first-page":"827","article-title":"Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy","volume":"80","author":"Nachtigall","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib6","doi-asserted-by":"crossref","unstructured":"The writing group for the PEPI trial. Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. J. Am. Med. Assoc. 273 (1995) 1999\u20132208.","DOI":"10.1001\/jama.1995.03520270033028"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib7","doi-asserted-by":"crossref","unstructured":"Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. Lancet 350 (1997) 1047\u20131059.","DOI":"10.1016\/S0140-6736(97)08233-0"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0749-3797(99)00078-1","article-title":"Hormone replacement therapy and breast cancer risk in a nationally representative cohort","volume":"17","author":"Lando","year":"1999","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"year":"2001","series-title":"\u00c9pid\u00e9miologie des l\u00e9sions malignes du sein. Encycl M\u00e9d Chir","author":"Espi\u00e9","key":"10.1016\/j.jsbmb.2007.03.033_bib10"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","article-title":"Breast cancer risk following long-term oestrogen and estrogen-progestins-replacement therapy","volume":"81","author":"Magnusson","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib12","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long durations and different regimens of hormone therapy and risk of breast cancer","volume":"289","author":"Li Ch","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1067\/mob.2003.201","article-title":"Progestins and breast cancer","volume":"188","author":"Eden","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone replacement therapy in younger and older women","volume":"19","author":"Salpeter","year":"2004","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib15","article-title":"Critique of the report from de Writing Group of the WHI","volume":"vol. 10","author":"Goodman","year":"2003"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2005.02.007","article-title":"Recent insight on the control of enzyme involved in estrogen formation and transformation in human breast cancer","volume":"93","author":"Pasqualini","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajog.2004.04.041","article-title":"Dose of progestins in postmenopausal-combined hormone therapy and risk of endometrial cancer","volume":"191","author":"Reed","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib18","first-page":"302","article-title":"Role of progesterone receptors in breast cancer","volume":"36","author":"McGuire","year":"1986","journal-title":"CA"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5694\/j.1326-5377.1988.tb99424.x","article-title":"Oestrogen therapy after the menopausal\u2014boon or bone?","volume":"148","author":"Armstrong","year":"1988","journal-title":"Med. J. Aust."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2007.03.033_bib20","first-page":"S159","article-title":"Hormone replacement therapy (HRT) may not increase the incidence of breast cancer in Japan","volume":"94","author":"Saeki","year":"2005","journal-title":"Breast Cancer Res. Treatment"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib21","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ajog.2005.07.085","article-title":"WHI clinical trial revisit: imprecise scientific methodology disqualifies the study's outcomes","volume":"193","author":"Ostrzenski","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2003.12.001","article-title":"The Million Women Study: a licence to kill other investigations","volume":"113","author":"van der Mooren","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib23","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1001\/jama.1985.03350370104033","article-title":"Family history and the risk of breast cancer","volume":"253","author":"Sattin","year":"1985","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib24","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer","volume":"91","author":"Constantino","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2007.03.033_bib25","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/01.CIR.96.7.2468","article-title":"Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association","volume":"96","author":"Mosca","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2007.03.033_bib26","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288 (2002) 321\u2013333.","DOI":"10.1001\/jama.288.3.321"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076007000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076007000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:54:06Z","timestamp":1760734446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076007000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":26,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0960076007000805"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2007.03.033","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidences of breast cancer throughout long-term hormone replacement therapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2007.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}